Clinical Trial Update: Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether serum hepcidin levels can predict response to oral or intravenous iron therapy in iron deficiency anemia. Results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Intravenous iron
• Oral iron (ferrous sulfate)

Snippet

Sponsor: American Regent, Inc. | Conditions: Iron Deficiency Anemia (IDA) | Phase 4 | Status: COMPLETED | Results posted: 2025-05-22